No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anilides / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Basal Cell / diagnostic imaging
-
Carcinoma, Basal Cell / drug therapy*
-
Carcinoma, Basal Cell / pathology
-
Compassionate Use Trials
-
Hemangiosarcoma / diagnostic imaging
-
Hemangiosarcoma / drug therapy*
-
Hemangiosarcoma / pathology
-
Humans
-
Immune Checkpoint Inhibitors / adverse effects
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Male
-
Molecular Targeted Therapy
-
Neoplasm Recurrence, Local*
-
Nivolumab / therapeutic use*
-
Pyridines / therapeutic use*
-
Skin Neoplasms / diagnostic imaging
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / pathology
-
Treatment Outcome
-
Xeroderma Pigmentosum / diagnostic imaging
-
Xeroderma Pigmentosum / drug therapy*
-
Xeroderma Pigmentosum / pathology
Substances
-
Anilides
-
HhAntag691
-
Immune Checkpoint Inhibitors
-
Pyridines
-
Nivolumab